Daré Bioscience

Board

• Jessica Grossman [1]
• Susan L. Kelley
• William H. Rastetter
• Robin Steele
• Gregory Matz
• Cheryl Blanchard

Acquired Microchips Biotech in December 2019

"Microchips’ innovative drug delivery technology is designed to store and precisely deliver hundreds of therapeutic doses over months or years in a single implant. The implant is intended to be operated by the patient to deliver medication on demand or on a pre-determined schedule that can be activated or deactivated wirelessly, as required.

"With the support of the The Bill & Melinda Gates Foundation in the form of approximately $17.9 million in grant funding to date, and the potential for up to an additional $2.5 million in grant funding in 2020, Microchips has been developing an implantable long-acting, reversible contraceptive application of the technology." [2]